Salix sales grew 28% last quarter

Discussion in 'Valeant Pharmaceuticals' started by anonymous, Dec 3, 2016 at 6:46 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    They been calling it that for almost two years now, so not just recently.
     

  2. anonymous

    anonymous Guest

    What happened to Salix growing 25% each quarter?? Has it stopped growing? Where are all the Valeant bulls?
     
  3. anonymous

    anonymous Guest

    Salix was a good company when Valeant bought it, but they totally misrepresented their potential (and MP was stupid enough to buy into it).

    Xifaxan is WAY below initial forecasts. Uceris is WAY below. Relistor Oral has no hope of hitting $1B... and so on.

    This PCP force is really going to have to knock the cover off the ball to make Salix a real growth business again...
     
  4. anonymous

    anonymous Guest

    everyone here is such a whiney loser
     
  5. anonymous

    anonymous Guest

    Yippie
     
  6. anonymous

    anonymous Guest

    All the predictions came true. Valeant bought Salix and destroyed everything that was great about the company. Salix has devolved into a metrics driven, big pharma, dumbed down mess being led by a blowhard bully with no GI background. All we do is busy work, online training, conference calls, call plan adherence reports, endless business plans and box checking. It’s mindless and sad.
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    Yesssss